Animal study · aged nonhuman primates
Klotho: one low dose enhanced memory in aged nonhuman primates
Checked against the paper Animal studyPublished by PepVault
The takeaway
In aged nonhuman primates, klotho's memory benefit appeared only at the low dose, and these animal results have not been shown in people.
- Kind
- Animal study
- Studied in
- Aged nonhuman primates
- Published
- 2023
- Journal
- Nat Aging
What they tested
The team tested whether giving klotho, a protein linked to longevity, could improve memory and thinking in aged nonhuman primates.
How the study was done
A preclinical animal study. The team first tested the rhesus form of the klotho protein in mice, then gave aged nonhuman primates one dose of klotho at either a low or a high level.

What they found
In mice, the rhesus form of klotho increased synaptic plasticity (how well connections between brain cells can strengthen) and improved cognition. In aged nonhuman primates, a single low dose of klotho enhanced memory. A single high dose did not.
What it doesn’t show
This is animal work in mice and nonhuman primates, not a result in people. Each primate got only one dose, so the effects of repeated or longer treatment were not tested.
The paper
Castner et al. Longevity factor klotho enhances cognition in aged nonhuman primates. Nat Aging. 2023.
The compound
More studies on Klotho
- Klotho: higher genetic levels tied to lower atrial fibrillation riskMeta-analysis · people · 2022
- Klotho: higher levels improved learning and memory in miceAnimal study · mice · 2014
- Every study on Klotho
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.